{
  "title": "Plasmablast response to inactivated and live attenuated influenza vaccines (TIV3/TIV3 ID) in 2013",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY472",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "Plasmablast response to inactivated and live attenuated influenza vaccines (TIV3/TIV3 ID) in 2013",
  "performedBy": [
    {
      "firstName": "Harry",
      "lastName": "Greenberg",
      "email": "hbgreen@stanford.edu",
      "affiliations": [
          {
             "name": "Stanford University"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "TIV group",
          "size": 18
        },
        {
          "name": "ID TIV group",
          "size": 5
        },
        {
          "name": "CyTOF control samples",
          "size": 1
        }
  ],
  
  "usesReagent": [
        {
          "name": "CyTOF_PBS"
        },
        {
          "name": "CyTOF_EDTA"
        },
        {
          "name": "CyTOF_Bovine Serum Albumin"
        },
        {
          "name": "CyTOF_16% paraformaldehyde"
        },
        {
          "name": "CyTOF_Permeabilization buffer"
        },
        {
          "name": "CyTOF_Antibody Stabilizer buffer-PBS"
        },
        {
          "name": "CyTOF_DOTA-maleimide"
        },
        {
          "name": "CyTOF_CD19 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD4 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD8 antibody-unconjugated"
        },
        {
          "name": "CyTOF_IgD antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD85j antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD16 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD3 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD38 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD27 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD14 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD94 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CCR7 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD45RA antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD20 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD127 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD33 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD28 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD24 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD161 antibody-unconjugated"
        },
        {
          "name": "CyTOF_TCRgd antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD56 antibody-unconjugated"
        },
        {
          "name": "CyTOF_HLADR antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD25 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD57 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD11c antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD11b antibody-unconjugated"
        },
        {
          "name": "CyTOF_CCR6 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD86 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CXCR3 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CXCR5 antibody-unconjugated"
        },
        {
          "name": "CyTOF_ICOS antibody-unconjugated"
        },
        {
          "name": "CyTOF_PD-1 antibody-unconjugated"
        },
        {
          "name": "CyTOF_CD123 antibody-unconjugated"
        },
        {
          "name": "CyTOF_Indium III) chloride, In113 enriched"
        },
        {
          "name": "CyTOF_Nd142 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Nd143 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Nd144 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Nd146 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Sm147 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Nd148 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Sm149 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Nd150 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Eu151 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Sm152 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Eu153 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Sm154 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Gd155 (III) chloride"
        },
        {
          "name": "CyTOF_Gd156 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Gd157 (III) chloride"
        },
        {
          "name": "CyTOF_Gd158 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Gd160 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Dy162 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Dy164 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Er166 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Er167 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Er168 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Er170 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Yb171 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Yb172 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Yb173 (III) chloride"
        },
        {
          "name": "CyTOF_Yb174 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Yb176 DN3 MAXPAR kit"
        },
        {
          "name": "CyTOF_Iridium intercalator"
        },
        {
          "name": "CyTOF_Terbium (III) chloride"
        },
        {
          "name": "CyTOF_Lutetium (III) chloride"
        },
        {
          "name": "CyTOF_Holmium (III) chloride"
        },
        {
          "name": "CyTOF_Thulium (III) chloride"
        },
        {
          "name": "CyTOF_Indium (III) chloride"
        },
        {
          "name": "CyTOF_CyPBS"
        },
        {
          "name": "CyTOF_CyFACS"
        },
        {
          "name": "CyTOF_Indium-DOTA-maleimide"
        },
        {
          "name": "CyTOF_CD57-In113"
        },
        {
          "name": "CyTOF_CD19-Nd142"
        },
        {
          "name": "CyTOF_CD4-Nd143"
        },
        {
          "name": "CyTOF_CD8-Nd144"
        },
        {
          "name": "CyTOF_IgD-Nd146"
        },
        {
          "name": "CyTOF_CD85j-Sm147"
        },
        {
          "name": "CyTOF_CD11c-Nd148"
        },
        {
          "name": "CyTOF_CD16-Sm149"
        },
        {
          "name": "CyTOF_CD3-Nd150"
        },
        {
          "name": "CyTOF_CD38-Eu151"
        },
        {
          "name": "CyTOF_CD27-Sm152"
        },
        {
          "name": "CyTOF_CD11b-Eu153"
        },
        {
          "name": "CyTOF_CD14-Sm154"
        },
        {
          "name": "CyTOF_CCR6-Gd155"
        },
        {
          "name": "CyTOF_CD94-Gd156"
        },
        {
          "name": "CyTOF_CD86-Gd157"
        },
        {
          "name": "CyTOF_CXCR5-Gd158"
        },
        {
          "name": "CyTOF_CXCR3-Tb159"
        },
        {
          "name": "CyTOF_CCR7-Gd160"
        },
        {
          "name": "CyTOF_CD45RA-Dy162"
        },
        {
          "name": "CyTOF_CD20-Dy164"
        },
        {
          "name": "CyTOF_CD127-Ho165"
        },
        {
          "name": "CyTOF_CD33-Er166"
        },
        {
          "name": "CyTOF_CD28-Er167"
        },
        {
          "name": "CyTOF_CD24-Er168"
        },
        {
          "name": "CyTOF_ICOS-Tm169"
        },
        {
          "name": "CyTOF_CD161-Er170"
        },
        {
          "name": "CyTOF_TCRgd-Yb171"
        },
        {
          "name": "CyTOF_PD-1-Yb172"
        },
        {
          "name": "CyTOF_CD123-Yb173"
        },
        {
          "name": "CyTOF_CD56-Yb174"
        },
        {
          "name": "CyTOF_HLADR-Lu175"
        },
        {
          "name": "CyTOF_CD25-Yb176"
        },
        {
          "name": "SLVP021_2012_CyTOFreagentset"
        },
        {
          "name": "Custom  63 plex Magnetic Bead array  kit for Luminex"
        },
        {
          "name": "Phosphate Buffer Saline"
        },
        {
          "name": "Sodium Chloride"
        },
        {
          "name": "Chicken Red Blood Cells"
        },
        {
          "name": "Receptor Destroying Enzyme II"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "18-32"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "willing to complete informed consent"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "available for follow up"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Acceptable medical history and vital signs"
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Received TIV in 2010 or 2011"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Prior off-study vaccination with the current 2012-2013 seasonal TIV or LAIV"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Most recent flu vaccination (in either the 2010 or 2011 flu season) was given by intranasal (LAIV) vaccine."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Allergy to egg or egg products, or to vaccine components or thimerosal (TIV multidose vials only)."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Life-threatening reactions to previous influenza vaccinations"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Active systemic or serious concurrent illness, including febrile illness on the day of vaccination"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "History of immunodeficiency (including HIV infection)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Known or suspected impairment of immunologic function, including, but not limited to, clinically significant liver disease, diabetes mellitus treated with insulin, moderate to severe renal disease, or any other chronic disorder which, in the opinion of the investigator, might jeopardize volunteer safety or compliance with the protocol."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Blood pressure >150 systolic or >95 diastolic at first study visit"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Hospitalization in the past year for congestive heart failure or emphysema."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Chronic Hepatitis B or C."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Recent or current use of immunosuppressive medication, including systemic glucocorticoids (corticosteroid nasal sprays, inhaled steroids and topical steroids are permissible in both groups)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Malignancy, other than squamous cell or basal cell skin cancer (includes solid tumors such as breast cancer or prostate cancer with recurrence in the past year, and any hematologic cancer such as leukemia)."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Autoimmune disease (including rheumatoid arthritis treated with immunosuppressive medication such as Plaquenil, methotrexate, prednisone, Enbrel)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Use of any anti-coagulation medication such as Coumadin or Lovenox, or anti-platelet agents such as aspirin (except up to 325 mg. aspirin per day), Plavix, or Aggrenox must be reviewed by investigator to determine if this would affect the volunteer?s safety."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Receipt of blood or blood products within the past 6 months or planned receipt of blood products prior to completion of study visits."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Medical or psychiatric condition or occupational responsibilities that preclude participant compliance with the protocol"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Inactivated vaccine 14 days prior to vaccination or planned non-study vaccination prior to completion of Visit 03 (~Day 28 after the study vaccination)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Live, attenuated vaccine within 60 days of vaccination or planned non-study vaccination prior to completion of Visit 03 (~Day 28 after the study vaccination)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Need an allergy immunization (that cannot be postponed) during the study period V01 to V03 (~Day 28)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "History of Guillain?Barr? Syndrome"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Pregnant or lactating woman"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Use of investigational agents within 30 days prior to enrollment or planned use of investigational agents prior to completion of study visits"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Donation of the equivalent of a unit of blood within 6 weeks prior to enrollment or planned blood donation prior to completion of study visits."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Any condition which, in the opinion of the investigator, might interfere with volunteer safety, study objectives or the ability of the participant to understand or comply with the study protocol."
          ]
        }
  ],
  
  "types": [
      {
          "value": "Interventional"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Harry",
      "lastName": "Greenberg",
      "email": "hbgreen@stanford.edu",
      "affiliations": [
          {
             "name": "Stanford University"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Vaccination and infection: indicators of immunological health and responsiveness",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "AI090019"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "This U19 application focuses on three interrelated questions in human immunology, namely: (1) What distinguishes an effective from an ineffective immune response to a vaccine? (2) How do responses elicited by a vaccine against a particular pathogen differ from those associated witti actual infection and disease caused by the pathogen? (3) Given that a range of effective responses is likely to occur in response to a vaccine or infection, what does this variation tell us about key parameters of immunological health?  http://projectreporter.nih.gov/project_info_details.cfm?aid=8705360&icde=23811246&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Interventional"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2013-09-01",
          "type": {
              "value": "actual_start_date"
          }
      },
      {
          "date": "2016-06-17",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Cellular Phenotype"
        },
        "description": "CyTOF surface phenotyping, day 0",
        "types": [
            {
               "value": "CyTOF"
            }
        ]
      },{
        "name": {
            "value": "Cytokine Quantification"
        },
        "description": "None",
        "types": [
            {
               "value": "Luminex xMAP"
            }
        ]
      },{
        "name": {
            "value": "Virus Titer"
        },
        "description": "None",
        "types": [
            {
               "value": "Hemagglutination Inhibition"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "PBMC extraction protocol"
        },
        {
          "name": "SLVP021_2013_MBAAtreatment"
        },
        {
          "name": "HAI_treat"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY472",
              "identifierSource": "ImmPort"
          },
          "title": "Plasmablast response to inactivated and live attenuated influenza vaccines (TIV3/TIV3 ID) in 2013",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY472",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Vaccination and infection: indicators of immunological health and responsiveness",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=8527698&icde=23840268&ddparam=&ddvalue=&ddsub=&cr=2&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "To study the plasmablast response to 2012 seasonal inactivated infuenza vaccine."
}
